Clinical Trial Update: Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating interferon alfa-2b with or without radiation therapy in patients with metastatic melanoma to regional lymph nodes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon alfa-2b (interferon alfa-2b)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Melanoma (Skin) | Phase 3 | Status: COMPLETED